HCM Q4 2021 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q4 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$138M+128.0% YoY

Gross Profit

$8M5.9% margin

Operating Income

$203M146.9% margin

Net Income

-$27M-19.3% margin

EPS (Diluted)

$-0.27

QoQ Revenue Growth

+39.0%

Cash Flow

Operating Cash Flow

-$66M

Free Cash Flow

-$70M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$333M

Stockholders' Equity

$987M

Cash & Equivalents

$378M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$138M	$61M	+128.0%
Gross Profit	$8M	-$42M	+119.3%
Operating Income	$203M	-$59M	+442.6%
Net Income	-$27M	-$38M	+30.0%